Rich_by_the_Bay
Moderator Emeritus
I'm glad to see that this panel agree with my evaluation:
An discussion hidden in this meta-analysis study (but not included in the excerpt) supports the fact that if you have just one or two baseline PSAs under 1 or so around age 60, your risk of dying from prostate cancer are low enough that screening thereafter is of no mortality benefit.
Apparently that eliminates the "first pass" effect of picking up the early positive results (mostly false alarms) when screening is started, which then drops drastically thereafter.
I agree with the science behind the USPHS recommendations.